Click to Share
 

Stem Cells Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By MD Stem Cellls
Stem Cell Ophthalmology Treatment Study publications advance stem cell research
By Stemedica International
Peer-reviewed Research Published in Nature's "Scientific Reports"
By Blue Horizon International
Brian Mehling, M.D., world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, and founder of Blue Horizon International (BHI), will be attending the 47th Annual World Economic Forum (WEF) in Davos from January 17-20, 2017.
By Stemedica International
The Only Alzheimer's Disease Clinical Trial Using Stemedica's Ischemia-Tolerant Mesenchymal Stem Cells (itMSCs) Continues Recruitment at UCI
By Hinsdale Foot & Ankle Specialist
Hinsdale Foot & Ankle Specialist is now offering stem cell recruitment therapy to help patients with foot and ankle pain. The regenerative medicine treatments are offered by Dr. Kevin Salvino, a Board Certified DPM.
By Stemedica International
Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s Disease announced today that its Chief Scientist, Tristan Bolmont, PhD, will present at the upcoming 14th International Athens /...
By Stemedica International
Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s Disease announced today that it has received IRB approval from Emory University in Atlanta, Georgia to initiate a clinical study entitled,...
12503350
By Blue Horizon International
The Blue Horizon Charitable Foundation (BHCF) recently hosted its fourth annual gala at The Water Club, one of New York City’s most famous landmarks situated on the East River and surrounded by incredible cityscape views.
12506870
By Blue Horizon International
Brian Mehling, M.D., board-certified orthopedic surgeon and CMO of Blue Horizon International, presents data from “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation" at...
12503361
By Blue Horizon International
Top US-Australian Scientists Start a Brain Mapping Initiative Aiming at Breaking New Ground in Innovation, Translation, and Commercialization of Neuro-technology
By Stemedica International, SA
Stemedica International, a subsidiary of Stemedica Cell Technologies, Inc.
12444371
By Blue Horizon International
Blue Horizon International (BHI) further extends its international reach with the opening of its stem cell laboratory and treatment facility in Central Europe
12469846
By Obi Plastic Surgery
Renowned plastic surgeon and stem cell therapy pioneer Dr. Lewis Obi is proud to announce the formation of the Stem Cell Surgical Network of Florida.
12449096
By Blue Horizon International
Highly regarded stem cell-researcher and board-certified orthopedic surgeon introduced studies on high-potency stem cell treatments at a medical conference
12442165
By Blue Horizon International
Brian Mehling, M.D., a board-certified orthopedic surgeon and CMO of Blue Horizon International (BHI), will deliver his presentation “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic...
12441325
By Blue Horizon International
Dr. Brian Mehling, an alumni of Wright State University Boonshoft School of Medicine, will be a keynote speaker at Orthopaedic Research and Innovation Symposium
12417517
By MoBiTec GmbH
The goal of the Spring Meeting 2015, entitled "21st Century Genetics", is to bring together top international scientists who are revolutionizing the investigation of biology and genetics through innovative methods and approaches.
By BioMagnetic Solutions
Advancing the Science of Magnetic Separations December 16, 2014 For More Information: Ted Liberti/COO & VP Business Development info@BioMagneticSolutions.com 1.814.689.1801 Bio-Tech Company’s Newest Innovation Detects Cancer Stem Cells Sooner State...
12404612
By Blue Horizon International
Blue Horizon Stem Cells, a division of Blue Horizon International, a healthcare consulting company that combines cutting-edge stem cell therapies to emerging markets, is sponsoring mixed martial artist, Lance Palmer, at the World Series of Fighting on...
By Doreen Santora
Blue Horizon Charitable Foundation announced today, on #GivingTuesday, that it has created a special restricted campaign to help raise funds for two brothers from Slovakia who both suffer from a rare genetic disorder.

All Press Releases

By Mary Ann Liebert, Inc., publishers
As the brain has limited capability for self-repair or regeneration, stem cells may represent the best therapeutic approach for counteracting damage to or degeneration of brain tissue caused by injury, aging, or disease.
By Mary Ann Liebert, Inc., publishers
Virotherapy capable of destroying tumor cells and activating anti-tumor immune reactions, and the use of engineered hematopoietic stem cells (HSCs) to deliver replacement genes that have the potential to cure blood diseases are among the key areas of...
By Mary Ann Liebert, Inc., publishers
A growing body of clinical evidence shows that transplantation of a patient's own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn's disease-related fistula can be a safe and effective addition to surgery.
By Mary Ann Liebert, Inc., publishers
New research has shown that the success of transplanting stem cells into the brain to regenerate tissue damaged by stroke may depend on the maturity of the neuronal precursor cells used for transplantation.
By Advancells
Advancells has excelled in its category, showing fantastic progress in technical innovation and quality excellence. This award is a testament to the skills, ingenuity and vision of its founders.
By Dr. Lox
Dr. Dennis Lox an expert in stem cell medicine presented his experience in the field of stem cell medicine with athletes, sports medicine, and osteoarthritis patients in The New Jersey meeting May 16-18, 2017.
By Mary Ann Liebert, Inc., publishers
Researchers have shown that following a stroke-induced ischemic injury to the human brain, stem cells are produced that have the potential to differentiate and mature to form neurons that can help repair the damage to the brain.
By StemGenn Therapeutics
StemGenn Therapeutics is a leading name that supports the development and commercialization of cellular therapies and stem cell research.
By MD Stem Cellls
Stem Cell Ophthalmology Treatment Study publications advance stem cell research
By Sports and Regenerative Medicine
PRESS RELEASE Los Angeles, California Dr. Dennis Lox has treated many patients with Avascular Necrosis (AVN) and stem cells. Dr.
By Mary Ann Liebert, Inc., publishers
An esteemed panel of scientists and clinicians with expertise in developmental biology and toxicology examined the potential benefits and current limitations of using stem cell-based tissue and organ models to screen for the toxicity of chemicals and...
By Sports and Regenerative Medicine
Medicine is constantly changing. The same is true for stem cell science and Regenerative Medicine in general. The knee has arguably been given the most attention in musculoskeletal and sports medicine as it relates to stem cell treatments. Dr.
By MD Stem Cells
Physicians from seat of Nobel Prize seek collaboration with Dr. Jeffrey Weiss and MD Stem Cells
By Mary Ann Liebert, Inc., publishers
Researchers have demonstrated the potential to engineer brown adipose tissue, which has therapeutic promise to treat metabolic diseases such as obesity and type 2 diabetes, from white adipose-derived stem cells (ASCs).
By Stemedica International
Peer-reviewed Research Published in Nature's "Scientific Reports"
By Blue Horizon International
Brian Mehling, M.D., world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, and founder of Blue Horizon International (BHI), will be attending the 47th Annual World Economic Forum (WEF) in Davos from January 17-20, 2017.
By Stemedica International
The Only Alzheimer's Disease Clinical Trial Using Stemedica's Ischemia-Tolerant Mesenchymal Stem Cells (itMSCs) Continues Recruitment at UCI
By MD Stem Cells
MD Stem Cells executive and study director of key stem cell clinical trials to guide principal medical journal
By MJRC clinic
Knee replacement versus signaling cell treatment for osteoarthritis
By RestoraLife™
Stem Cell and PRP (platelet rich plasma) treatments have been at the forefront of medical research for many years now.
By Credence Research
The Hematopoietic stem cells transplantation market was valued at USD 3,741.3 Mn in 2015, and is expected to reach USD 7,796.1 Mn by 2022
By Hinsdale Foot & Ankle Specialist
Hinsdale Foot & Ankle Specialist is now offering stem cell recruitment therapy to help patients with foot and ankle pain. The regenerative medicine treatments are offered by Dr. Kevin Salvino, a Board Certified DPM.
By Stemedica International
Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s Disease announced today that its Chief Scientist, Tristan Bolmont, PhD, will present at the upcoming 14th International Athens /...
By Stemedica International
Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s Disease announced today that it has received IRB approval from Emory University in Atlanta, Georgia to initiate a clinical study entitled,...
12503350
By Blue Horizon International
The Blue Horizon Charitable Foundation (BHCF) recently hosted its fourth annual gala at The Water Club, one of New York City’s most famous landmarks situated on the East River and surrounded by incredible cityscape views.
12506870
By Blue Horizon International
Brian Mehling, M.D., board-certified orthopedic surgeon and CMO of Blue Horizon International, presents data from “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation" at...
12503361
By Blue Horizon International
Top US-Australian Scientists Start a Brain Mapping Initiative Aiming at Breaking New Ground in Innovation, Translation, and Commercialization of Neuro-technology
By Regen Medical PC
Dr. Steven Victor, CEO of Regen Medical, PC, a New York regenerative medicine company, announced today that the Journal of the American Society for Artificial Internal Organs, has published a case study entitled “First in Man: Sternal Reconstruction...
By Industry Experts
Industry Experts has today released the new updated 2015 version of market research report on Tissue Engineering.
By Stemedica International, SA
Stemedica International, a subsidiary of Stemedica Cell Technologies, Inc.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share